Relationships Between Clinico-Epidemiological Patterns of Invasive Meningococcal Infections and Complement Deficiencies in French South Pacific Islands (New Caledonia)

Journal of Clinical Immunology

Volumn 35, Issue 1, 2015, Pages 47-55

  Daures, Maguy ^a   John, Michele ^a   Balter, Cécile Veysseyre ^b   Simon, Olivier ^c   Barguil, Yann ^c   Missotte, Isabelle ^c   Grangeon, Jean Paul ^a   Laumond Barny, Sylvie ^a   Noel, Martine ^a   Besson Leaud, Laurent ^c   Spasic, Pierre Emmanuel ^c   de Suremain, Aurélie ^c   Gourinat, Ann Claire ^d   Descloux, Elodie ^c  

^a Public Health Service   (New Caledonia)

^b UNIVERSITÉ LYON 1   (France)

^c Noumea Territorial Hospital   (New Caledonia)

^d Institut Pasteur de Nouvelle Caledonie Noumea   (New Caledonia)

Author keywords

Complement deficiency; melanesian population; meningococcal disease; risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASPLENIA; CHILD; COMPLEMENT DEFICIENCY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; INTENSIVE CARE; INVASIVE MENINGOCOCCAL DISEASE; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NEW CALEDONIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEROTYPE; BACTEREMIA; DEFICIENCY; IMMUNOLOGY; INFANT; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; MIDDLE AGED; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

COMPLEMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS, SEROGROUP B; NEISSERIA MENINGITIDIS, SEROGROUP W-135; NEISSERIA MENINGITIDIS, SEROGROUP Y; NEW CALEDONIA; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84943588945     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0104-6     Document Type: Article

References (38)

1. Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J. 2004;23(12 Suppl):S274–9.
2. Caro JJ, Möller J, Getsios D, et al. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. BMC Public Health. 2007;7:130.
3. World Health Organization. Control of epidemic meningococcal disease. WHO practical guidelines. 2nd edition WHO/EMC/BAC/98.3. Available at: http://www.who.int/csr/resources/publications/meningitis/whoemcbac983.pdf. Accessed 1998.
4. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27 Suppl 2:B51–63. doi:10.1016/j.vaccine.2009.04.063. Review.
5. Jones DM, Mallard RH. Age incidence of meningococcal infection England and Wales, 1984–1991. J Infect. 1993;27:83–8.
6. McCall BJ, Neill AS, Young MM. Risk factors for invasive meningococcal disease in southern Queensland, 2000–2001. Intern Med J. 2004;34(8):464–8.
7. Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997;16(10):979–83.
8. Kriz P, Bobak M, Kriz B. Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case–control study. Arch Dis Child. 2000;83(2):117–21.
9. Stanwell-Smith RE, Stuart JM, Hughes AO, Robinson P, Griffin MB, Cartwright K. Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect. 1994;112(2):315–28.
10. Deutch S, Labouriau R, Schønheyeder HC, et al. Crowding as a risk factor of meningococcal disease in Danish preschool children: a nationwide population-based case–control study. Scand J Infect Dis. 2004;36(1):20–3.
11. Baker M, McNicholas A, Garrett N, et al. Household crowding a major risk factor for epidemic meningococcal disease in Auckland children. Pediatr Infect Dis J. 2000;19(10):983–90.
12. Kallel-Sellami M, Abdelmalek R, Zerzeri Y, et al. Complement protein hereditary deficits during purulent meningitis: study of 61 adult Tunisian patients. Arch Inst Pasteur Tunis. 2006;83(1–4):25–34. French.
13. Densen P. Complement deficiencies and meningococcal disease. Clin Exp Immunol. 1991;86 Suppl 1:57–62. Review.
14. Bona G, Guidi C. Meningococcal vaccine evolution. J Prev Med Hyg. 2012;53(3):131–5.
15. Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore). 1984;63:243–73.
16. Overturf GD. Indications for the immunological evaluation of patients with meningitis. Clin Infect Dis. 2003;36:189–94.
17. Ellison 3rd RT, Kohler PF, Curd JG, Judson FN, Reller LB. Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med. 1983;308(16):913–6.
18. Revest M, Michelet C. Predisposing factors of community acquired bacterial meningitis (excluding neonates). Med Mal Infect. 2009;39(7–8):562–71.
19. Skattum L, van Deuren M, van der Poll T, Truedsson L. Complement deficiency states and associated infections. Mol Immunol. 2011;48(14):1643–55.
20. Fijen CAP, Kuijper EJ, Tjia HG, Daha MR, Dankert J. Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis. 1994;18:780–4.
21. Fijen CA, van den Bogaard R, Schipper M, et al. Properdin deficiency: molecular basis and disease association. Mol Immunol. 1999;36(13–14):863–7.
22. Nielsen HE, Koch C, Magnussen P, Lind I. Complement deficiencies in selected groups of patients with meningococcal disease. Scand J Infect Dis. 1989;21:389–96.
23. Sjöholm AG, Jönsson G, Braconier JH, Sturfelt G, Truedsson L. Complement deficiency and disease: an update. Mol Immunol. 2006;43:78–85.
24. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 1991;4(3):359–95.
25. Platonov AE, Vershinina IV, Käyhty H, Fijen CA, Würzner R, Kuijper EJ. Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component deficient patients. Int Arch Allergy Immunol. 2003;130:314–21.
26. Parent du Châtelet I, Taha M-K, Lepoutre A, Deghmane A-E, Maine C, Lévy-Bruhl D. Invasive meningococcal disease in France, 2009. Weekly epidemiological bulletin (B.E.H) of French National Institute for Public Health Surveillance (InVS) n° 31–32. French. Available at: http://www.invs.sante.fr/beh/2010/31_32/. Accessed 27 July 2010.
27. Noel M Invasive meningococcal disease in New Caledonia: epidemiology and comparison of strains B with existing vaccine strains. Diplomae of vaccinology. University of Victor Segalen, Bordeaux 2, French New-caledonia 2010.
28. French Ministry of Health and Sports. National recommendations and policy regarding prophylaxis of invasive meningococcal diseases (DGS/5C/2006/458). Paris: 2006. French. Available at: http://www.infectiologie.com/site/medias/_documents/officiels/meningo_circ_2006.pdf. Accessed 23 Oct 2006.
29. Botto M, Kirschfink M, Macor P, Pickering MC, Würzner R, Tdesco F. Complement in human diseases: lessons from complement deficiencies. Mol Immunol. 2009;46:2774–83.
30. Nagata M, Hara T, Aoki T, et al. Inherited deficiency of ninth component of complement: an increased risk of meningococcal meningitis. J Pediatr. 1989;114(2):260–4.
31. Rameix-Welti MA, Chedani H, Blouin J, Alonso JM, Fridman WH, Fremeaux-Bacchi V. Neisseria meningitidis infection. Clinical criteria orienting towards a deficiency in the proteins of the complement. Presse Med. 2005;34(6):425–30. French.
32. Mayatepek E, Grauer M, Hänsch GM, Sonntag HG. Deafness, complement deficiencies and immunoglobulin status in patients with meningococcal diseases due to uncommon serogroups. Pediatr Infect Dis J. 1993;12(10):808–11.
33. Tedesco F. Inherited complement deficiencies and bacterial infections. Vaccine. 2008;26 suppl 8:13–8.
34. Fijen CAP, Kuijper EJ, Drogari-Apiranthitou M, Van Leeuwen Y, Daha MR, Dankert J. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol. 1998;114:362–9.
35. Rameix-Welti MA, Régnier CH, Bienaimé F, Blouin J, Schifferli J, Fridman WH, et al. Hereditary complement C7 deficiency in nine families: Subtotal C7 deficiency revisited. Eur J Immunol. 2007;37:1377–85.
36. Høgåsen K, Michaelsen T, Mellbye OJ, Bjune G. Low prevalence of complement deficiencies among patients with meningococcal disease in Norway. Scand J Immunol. 1993;37(4):487–9.
37. Ernst T, Späth PJ, Aebi C, Schaad UB, Bianchetti MG. Screening for complement deficiency in bacterial meningitis. Acta Paediatr. 1997;86(9):1009–10.
38. Fijen CA, Kuijper EJ, te Bulte MT, Daha MR, Dankert J. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis. 1999;28(1):98–105.